Morbidity and Mortality in Patients with Perioperative COVID-19 Infection: Prospective Cohort in General, Gastroesophagic, Hepatobiliary, and Colorectal Surgery.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
accepted:
06
03
2021
pubmed:
23
3
2021
medline:
28
5
2021
entrez:
22
3
2021
Statut:
ppublish
Résumé
Severe acute respiratory syndrome due to coronavirus 2 has rapidly spread worldwide in an unprecedented pandemic. Patients with an ongoing COVID-19 infection requiring surgery have higher risk of mortality and complications. This study describes the mortality and morbidity in patients with perioperative COVID-19 infection undergoing elective and emergency surgeries. Prospective cohort of consecutive patients who required a general, gastroesophageal, hepatobiliary, colorectal, or emergency surgery during COVID-19 pandemic at an academic teaching hospital. The primary outcome was 30-day mortality and major complications. Secondary outcomes were specific respiratory mortality and complications. A total of 701 patients underwent surgery, 39 (5.6%) with a perioperative COVID-19 infection. 30-day mortality was 12.8% and 1.4% in patients with and without COVID-19 infection, respectively (p < 0.001). Major surgical complications occurred in 25.6% and 6.8% in patients with and without COVID-19 infection, respectively (p < 0.001). Respiratory complications occurred in 30.8% and 1.4% in patients with and without COVID-19 infection, respectively (p < 0.001). Mortality due to a respiratory complication was 100% and 11.1% in patients with and without COVID-19 infection, respectively (p < 0.006). 30-day mortality and surgical complications are higher in patients with perioperative COVID-19 infection. Indications for elective surgery need to be reserved for non-deferrable procedures in order to avoid unnecessary risks of non-urgent procedures.
Sections du résumé
BACKGROUND
Severe acute respiratory syndrome due to coronavirus 2 has rapidly spread worldwide in an unprecedented pandemic. Patients with an ongoing COVID-19 infection requiring surgery have higher risk of mortality and complications. This study describes the mortality and morbidity in patients with perioperative COVID-19 infection undergoing elective and emergency surgeries.
METHODS
Prospective cohort of consecutive patients who required a general, gastroesophageal, hepatobiliary, colorectal, or emergency surgery during COVID-19 pandemic at an academic teaching hospital. The primary outcome was 30-day mortality and major complications. Secondary outcomes were specific respiratory mortality and complications.
RESULTS
A total of 701 patients underwent surgery, 39 (5.6%) with a perioperative COVID-19 infection. 30-day mortality was 12.8% and 1.4% in patients with and without COVID-19 infection, respectively (p < 0.001). Major surgical complications occurred in 25.6% and 6.8% in patients with and without COVID-19 infection, respectively (p < 0.001). Respiratory complications occurred in 30.8% and 1.4% in patients with and without COVID-19 infection, respectively (p < 0.001). Mortality due to a respiratory complication was 100% and 11.1% in patients with and without COVID-19 infection, respectively (p < 0.006).
CONCLUSIONS
30-day mortality and surgical complications are higher in patients with perioperative COVID-19 infection. Indications for elective surgery need to be reserved for non-deferrable procedures in order to avoid unnecessary risks of non-urgent procedures.
Identifiants
pubmed: 33748925
doi: 10.1007/s00268-021-06068-6
pii: 10.1007/s00268-021-06068-6
pmc: PMC7982273
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1652-1662Références
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Br J Surg. 2020 Jun;107(7):e183-e185
pubmed: 32339259
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Cir Esp (Engl Ed). 2020 Jun - Jul;98(6):320-327
pubmed: 32336467
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
JAMA Surg. 2020 Aug 1;155(8):691-702
pubmed: 32530453
J Visc Surg. 2020 Jun;157(3S1):S13-S18
pubmed: 32381426
Cir Esp (Engl Ed). 2020 Dec;98(10):618-624
pubmed: 32768138
World J Surg. 2020 Jun;44(6):1695-1698
pubmed: 32246185
Ann Surg. 2020 Jul;272(1):e27-e29
pubmed: 32221117
J Laparoendosc Adv Surg Tech A. 2021 Mar;31(3):261-265
pubmed: 33325786
Ann Surg. 2020 Jul;272(1):e1-e2
pubmed: 32209891
Br J Surg. 2020 Jul;107(8):e262
pubmed: 32491190
Ann Med Surg (Lond). 2020 Dec;60:149-154
pubmed: 33133593
Cir Esp (Engl Ed). 2020 Nov;98(9):525-532
pubmed: 32408995
Eur Urol. 2020 Jul;78(1):118-120
pubmed: 32425302
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Surg Endosc. 2021 Nov;35(11):6300-6306
pubmed: 33140151
Surg Infect (Larchmt). 2020 May;21(4):301-308
pubmed: 32310715
Am Surg. 2020 Jun;86(6):596-598
pubmed: 32683976